KSA
AGN

Ken Stern & Associates’s Allergan plc AGN Stock Holding History

Ken Stern & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,196
Closed -$951K – 78
2015
Q1 		$951K Sell
3,196
-504
-14% -$144K 0.71% 29
2014
Q4 		$952K Buy
+3,700
New +$925K 0.74% 33

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ken Stern & Associates's AGN Position: Q2 2015 in Review

Ken Stern & Associates sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 3,196 shares — an estimated $951K sold.

Ken Stern & Associates first reported a position in AGN in Q4 2014 and held it in 2 quarters. The position peaked at $952K in Q4 2014. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Ken Stern & Associates reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Ken Stern & Associates sold 3,196 Allergan plc shares in Q2 2015, an estimated $951K.
  • Ken Stern & Associates first reported a position in Allergan plc in Q4 2014 and held it in 2 quarters.
  • Ken Stern & Associates's Allergan plc position peaked at $952K in Q4 2014.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Ken Stern & Associates's 13F filing for Q2 2015, filed 18 Nov 2015.